E
Everest Medicines
Biotech & Life Sciences · New York City, United States · Founded 2017 · IPO 2020
Developing and commercialising novel transformative pharmaceutical therapies MoreLess
Everest Medicines was founded with a vision to address the critical need for innovative medicines in Asia. The company was co-founded by Wei Fu, who brought a wealth of experience from his previous roles in the pharmaceutical industry. Everest Medicines focuses on licensing, developing, and commercializing transformative pharmaceutical products that address critical unmet medical needs.
The company has strategically partnered with global biopharmaceutical companies to bring cutting-edge therapies to the Asian market. This approach has allowed Everest Medicines to build a robust pipeline of promising drug candidates across oncology, immunology, cardio-renal, and infectious diseases.
A significant milestone in Everest Medicines' journey was its successful IPO on the Hong Kong Stock Exchange in October 2020. This event marked a new chapter for the company, providing the necessary capital to accelerate its development programs and expand its commercial capabilities.
Everest Medicines continues to leverage its strong partnerships and innovative pipeline to make a meaningful impact on patients' lives in Asia. The company's commitment to addressing unmet medical needs remains at the core of its mission, driving its growth and success in the biopharmaceutical industry.
Talent graph
Everest Medicines's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Everest Medicines has talent and traffic
team presence
across markets
Patent intelligence
$16M patent portfolio · 10 active families
Where Everest Medicines concentrates vs peers
Each axis is a top-10 topic across Everest Medicines and its closest peers. #1 = 100, #10 = 10, absent = 0.
Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.
Market sentiment
What the market is saying about Everest Medicines
An AI-synthesized read of the highest-engagement posts about Everest Medicines on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Everest Medicines on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.